GMI

Adjuvants in vaccines may trigger innate cells response by toll-like receptors, thus eliciting a possible non-IgE mediated allergy phenomenon or causing B-cell activation and autoimmunity.


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *